PUBLISHER: 360iResearch | PRODUCT CODE: 1464946
PUBLISHER: 360iResearch | PRODUCT CODE: 1464946
Alvimopan Market by Therapeutic Application (Opioid-Induced Constipation, Postoperative Ileus Prevention), End-User (Hospitals, Surgical Centers) - Global Forecast 2024-2030
[189 Pages Report] The Alvimopan Market size was estimated at USD 6.20 billion in 2023 and expected to reach USD 6.51 billion in 2024, at a CAGR 5.23% to reach USD 8.87 billion by 2030.
Alvimopan is a medical compound categorized under the umbrella of peripherally acting μ-opioid receptor antagonists. Alvimopan is specifically designed to counteract the side effects of opioids on the bowel, thus aiding in the management of postoperative ileus, a condition where the bowel becomes temporarily paralyzed after abdominal surgery, inhibiting normal bowel functions. The global rise in surgical interventions, especially abdominal surgeries, directly correlates with the increasing demand for postoperative care solutions such as Alvimopan. Growing awareness and management strategies for opioid-induced complications further elevate the need for effective medications such as Alvimopan. Improved healthcare facilities and an emphasis on reducing hospital stays and healthcare costs propel the adoption of Alvimopan in clinical settings. However, strict regulations and long approval processes may delay market access for Alvimopan. Alvimopan carries the risk of side effects, which may create challenges for adoption among healthcare providers and patients. Moreover, developing healthcare infrastructure and increasing surgical procedures in emerging economies present significant growth opportunities. Collaborating with healthcare facilities and insurers to highlight the cost-effectiveness of using Alvimopan may create growth potential in the market.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 6.20 billion |
| Estimated Year [2024] | USD 6.51 billion |
| Forecast Year [2030] | USD 8.87 billion |
| CAGR (%) | 5.23% |
Therapeutic Application: Diverse scope of applications for easing opioid-Induced constipation
Alvimopan is used in opioid-induced constipation (OIC) by blocking the opioid effects on the gut, thus easing constipation without compromising pain management efficacy. Alvimopan serves as a crucial option for managing constipation symptoms in opioid-treated patients, in failure of first-line laxatives. Alvimopan is preferred for preventing POI, a proactive approach, allowing for faster gastrointestinal recovery and reduced hospitalization costs. Alvimopan is typically reserved for adult patients, undergoing elective bowel resection surgery.
End-User: Increasing preference for alvimopan in surgical centers for treating postoperative ileus
In hospitals, Alvimopan is predominantly used to enhance postoperative recovery, particularly after surgeries involving the gastrointestinal tract. The need for Alvimopan in these settings is driven by its ability to reduce length of hospital stays and lower the rates of postoperative ileus (POI). Surgical centers use Alvimopan to aid in the recovery of patients undergoing abdominal surgeries. Alvimopan's role in preventing POI is particularly valuable in maintaining the efficiency and patient satisfaction metrics critical to the surgical centers.
Regional Insights
In the Americas region, the U.S. and Canada are at the forefront in the Alvimopan market, largely due to FDA approval and its inclusion in postoperative care protocols in numerous hospitals. High healthcare spending, widespread availability of advanced medical facilities, and ongoing research contribute to its substantial use in the region. Alvimopan's adoption in the European Union varies by country, depending on national healthcare systems' policies, reimbursement practices, and the extent of awareness about postoperative care innovations. The awareness and use of Alvimopan are gradually growing, particularly in Gulf Cooperation Council (GCC) countries with robust healthcare systems. In the APAC region, the demand for Alvimopan in China is growing, driven by increasing surgical procedures and an expanding healthcare sector. Recent patents and research have stirred interest in Alvimopan, especially for its potential benefits in enhancing postoperative recovery in the elderly population, which is significant in Japan. The market for Alvimopan in India is nascent, given the rising healthcare infrastructure and increasing awareness about postoperative care.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Alvimopan Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alvimopan Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Alvimopan Market, highlighting leading vendors and their innovative profiles. These include Adolor Corporation, Adooq Bioscience LLC, Hikma Pharmaceuticals PLC, Manus Aktteva Biopharma LLP, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Alvimopan Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Therapeutic Application
- Opioid-Induced Constipation
- Postoperative Ileus Prevention
- End-User
- Hospitals
- Surgical Centers
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Americas
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Alvimopan Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alvimopan Market?
3. What are the technology trends and regulatory frameworks in the Alvimopan Market?
4. What is the market share of the leading vendors in the Alvimopan Market?
5. Which modes and strategic moves are suitable for entering the Alvimopan Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rise in surgical interventions including abdominal surgeries
- 5.1.1.2. Growing awareness and management strategies for opioid-induced complications
- 5.1.1.3. Improved healthcare facilities worldwide
- 5.1.2. Restraints
- 5.1.2.1. Strict regulations and long approval processes
- 5.1.3. Opportunities
- 5.1.3.1. R&D initiatives for exploring therapeutic applications of alvimopan
- 5.1.3.2. Increasing investments in public and private healthcare infrastructure
- 5.1.4. Challenges
- 5.1.4.1. Risk of associated side effects of alvimopan
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Therapeutic Application: Diverse scope of applications for easing opioid-Induced constipation
- 5.2.2. End-User: Increasing preference for alvimopan in surgical centers for treating postoperative ileus
- 5.3. Market Disruption Analysis
- 5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
- 5.5. Value Chain & Critical Path Analysis
- 5.6. Pricing Analysis
- 5.7. Technology Analysis
- 5.8. Patent Analysis
- 5.9. Trade Analysis
- 5.10. Regulatory Framework Analysis
6. Alvimopan Market, by Therapeutic Application
- 6.1. Introduction
- 6.2. Opioid-Induced Constipation
- 6.3. Postoperative Ileus Prevention
7. Alvimopan Market, by End-User
- 7.1. Introduction
- 7.2. Hospitals
- 7.3. Surgical Centers
8. Americas Alvimopan Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Alvimopan Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Alvimopan Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.3.1. Hikma Pharmaceuticals Launches Alvimopan Capsules for Enhanced Gastrointestinal Recovery in the US
- 11.4. Strategy Analysis & Recommendation
12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.2. Key Product Portfolio
LIST OF FIGURES
- FIGURE 1. ALVIMOPAN MARKET RESEARCH PROCESS
- FIGURE 2. ALVIMOPAN MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL ALVIMOPAN MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL ALVIMOPAN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. GLOBAL ALVIMOPAN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ALVIMOPAN MARKET DYNAMICS
- FIGURE 7. GLOBAL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
- FIGURE 8. GLOBAL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. GLOBAL ALVIMOPAN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 10. GLOBAL ALVIMOPAN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES ALVIMOPAN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES ALVIMOPAN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ALVIMOPAN MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 20. ALVIMOPAN MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. ALVIMOPAN MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL ALVIMOPAN MARKET SIZE, 2018-2023 (USD MILLION)
- TABLE 4. GLOBAL ALVIMOPAN MARKET SIZE, 2024-2030 (USD MILLION)
- TABLE 5. GLOBAL ALVIMOPAN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
- TABLE 6. GLOBAL ALVIMOPAN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
- TABLE 7. GLOBAL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 8. GLOBAL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 9. GLOBAL ALVIMOPAN MARKET SIZE, BY OPIOID-INDUCED CONSTIPATION, BY REGION, 2018-2023 (USD MILLION)
- TABLE 10. GLOBAL ALVIMOPAN MARKET SIZE, BY OPIOID-INDUCED CONSTIPATION, BY REGION, 2024-2030 (USD MILLION)
- TABLE 11. GLOBAL ALVIMOPAN MARKET SIZE, BY POSTOPERATIVE ILEUS PREVENTION, BY REGION, 2018-2023 (USD MILLION)
- TABLE 12. GLOBAL ALVIMOPAN MARKET SIZE, BY POSTOPERATIVE ILEUS PREVENTION, BY REGION, 2024-2030 (USD MILLION)
- TABLE 13. GLOBAL ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 14. GLOBAL ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 15. GLOBAL ALVIMOPAN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 16. GLOBAL ALVIMOPAN MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 17. GLOBAL ALVIMOPAN MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 18. GLOBAL ALVIMOPAN MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 19. AMERICAS ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 20. AMERICAS ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 21. AMERICAS ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 22. AMERICAS ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 23. AMERICAS ALVIMOPAN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
- TABLE 24. AMERICAS ALVIMOPAN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 25. ARGENTINA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 26. ARGENTINA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 27. ARGENTINA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 28. ARGENTINA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 29. BRAZIL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 30. BRAZIL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 31. BRAZIL ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 32. BRAZIL ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 33. CANADA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 34. CANADA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 35. CANADA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 36. CANADA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 37. MEXICO ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 38. MEXICO ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 39. MEXICO ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 40. MEXICO ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 41. UNITED STATES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 42. UNITED STATES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 43. UNITED STATES ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 44. UNITED STATES ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 45. UNITED STATES ALVIMOPAN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
- TABLE 46. UNITED STATES ALVIMOPAN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
- TABLE 47. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 48. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 49. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 50. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 51. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
- TABLE 52. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 53. AUSTRALIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 54. AUSTRALIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 55. AUSTRALIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 56. AUSTRALIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 57. CHINA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 58. CHINA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 59. CHINA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 60. CHINA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 61. INDIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 62. INDIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 63. INDIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 64. INDIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 65. INDONESIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 66. INDONESIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 67. INDONESIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 68. INDONESIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 69. JAPAN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 70. JAPAN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 71. JAPAN ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 72. JAPAN ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 73. MALAYSIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 74. MALAYSIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 75. MALAYSIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 76. MALAYSIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 77. PHILIPPINES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 78. PHILIPPINES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 79. PHILIPPINES ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 80. PHILIPPINES ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 81. SINGAPORE ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 82. SINGAPORE ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 83. SINGAPORE ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 84. SINGAPORE ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 85. SOUTH KOREA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 86. SOUTH KOREA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 87. SOUTH KOREA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 88. SOUTH KOREA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 89. TAIWAN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 90. TAIWAN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 91. TAIWAN ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 92. TAIWAN ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 93. THAILAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 94. THAILAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 95. THAILAND ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 96. THAILAND ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 97. VIETNAM ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 98. VIETNAM ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 99. VIETNAM ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 100. VIETNAM ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 101. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 102. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 103. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 104. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 105. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
- TABLE 106. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 107. DENMARK ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 108. DENMARK ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 109. DENMARK ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 110. DENMARK ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 111. EGYPT ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 112. EGYPT ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 113. EGYPT ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 114. EGYPT ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 115. FINLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 116. FINLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 117. FINLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 118. FINLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 119. FRANCE ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 120. FRANCE ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 121. FRANCE ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 122. FRANCE ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 123. GERMANY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 124. GERMANY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 125. GERMANY ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 126. GERMANY ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 127. ISRAEL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 128. ISRAEL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 129. ISRAEL ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 130. ISRAEL ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 131. ITALY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 132. ITALY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 133. ITALY ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 134. ITALY ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 135. NETHERLANDS ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 136. NETHERLANDS ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 137. NETHERLANDS ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 138. NETHERLANDS ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 139. NIGERIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 140. NIGERIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 141. NIGERIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 142. NIGERIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 143. NORWAY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 144. NORWAY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 145. NORWAY ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 146. NORWAY ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 147. POLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 148. POLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 149. POLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 150. POLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 151. QATAR ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 152. QATAR ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 153. QATAR ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 154. QATAR ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 155. RUSSIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 156. RUSSIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 157. RUSSIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 158. RUSSIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 159. SAUDI ARABIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 160. SAUDI ARABIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 161. SAUDI ARABIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 162. SAUDI ARABIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 163. SOUTH AFRICA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 164. SOUTH AFRICA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 165. SOUTH AFRICA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 166. SOUTH AFRICA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 167. SPAIN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 168. SPAIN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 169. SPAIN ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 170. SPAIN ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 171. SWEDEN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 172. SWEDEN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 173. SWEDEN ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 174. SWEDEN ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 175. SWITZERLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 176. SWITZERLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 177. SWITZERLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 178. SWITZERLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 179. TURKEY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 180. TURKEY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 181. TURKEY ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 182. TURKEY ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 183. UNITED ARAB EMIRATES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 184. UNITED ARAB EMIRATES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 185. UNITED ARAB EMIRATES ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 186. UNITED ARAB EMIRATES ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 187. UNITED KINGDOM ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
- TABLE 188. UNITED KINGDOM ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
- TABLE 189. UNITED KINGDOM ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 190. UNITED KINGDOM ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 191. ALVIMOPAN MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 192. ALVIMOPAN MARKET, FPNV POSITIONING MATRIX, 2023
